View in EDS HTML Full Text PDF Full Text

Effect of once-daily fluticasone furoate/vilanterol versus vilanterol alone on bone mineral density in patients with COPD: a randomized, controlled trial.

Saved in:
Bibliographic Details
Title: Effect of once-daily fluticasone furoate/vilanterol versus vilanterol alone on bone mineral density in patients with COPD: a randomized, controlled trial.
Authors: Maltais F; Centre de Recherche, Institut universitaire de cardiologie et de pneumologie de Québec, 2725 Chemin Sainte Foy, Québec City, QC, G1V 4G5, Canada., Schenkenberger I; Klinische Forschung Berlin GbR, Berlin, Germany., Wielders PLML; Department of Pulmonary Diseases, Catharina Hospital, Eindhoven, The Netherlands., Ortiz de Saracho J; Department of Pulmonary Diseases, El Bierzo Hospital, Ponferrada (León), Spain., Chinsky K; Chest Diseases of Northwestern PA, Erie, PA, USA., Watkins M; Respiratory Research and Development, GlaxoSmithKline plc., Research Triangle Park, NC, USA., Millar V; Biostatistics, GlaxoSmithKline plc., Uxbridge, UK., Crim C; Research and Development, GlaxoSmithKline plc., Research Triangle Park, NC, USA.
Source: Therapeutic advances in respiratory disease [Ther Adv Respir Dis] 2020 Jan-Dec; Vol. 14, pp. 1753466620965145.
Publication Type: Equivalence Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 101316317 Publication Model: Print Cited Medium: Internet ISSN: 1753-4666 (Electronic) Linking ISSN: 17534658 NLM ISO Abbreviation: Ther Adv Respir Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33081606
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effect of once-daily fluticasone furoate/vilanterol versus vilanterol alone on bone mineral density in patients with COPD: a randomized, controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Maltais+F%22">Maltais F</searchLink>; Centre de Recherche, Institut universitaire de cardiologie et de pneumologie de Québec, 2725 Chemin Sainte Foy, Québec City, QC, G1V 4G5, Canada.<br /><searchLink fieldCode="AU" term="%22Schenkenberger+I%22">Schenkenberger I</searchLink>; Klinische Forschung Berlin GbR, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Wielders+PLML%22">Wielders PLML</searchLink>; Department of Pulmonary Diseases, Catharina Hospital, Eindhoven, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Ortiz+de+Saracho+J%22">Ortiz de Saracho J</searchLink>; Department of Pulmonary Diseases, El Bierzo Hospital, Ponferrada (León), Spain.<br /><searchLink fieldCode="AU" term="%22Chinsky+K%22">Chinsky K</searchLink>; Chest Diseases of Northwestern PA, Erie, PA, USA.<br /><searchLink fieldCode="AU" term="%22Watkins+M%22">Watkins M</searchLink>; Respiratory Research and Development, GlaxoSmithKline plc., Research Triangle Park, NC, USA.<br /><searchLink fieldCode="AU" term="%22Millar+V%22">Millar V</searchLink>; Biostatistics, GlaxoSmithKline plc., Uxbridge, UK.<br /><searchLink fieldCode="AU" term="%22Crim+C%22">Crim C</searchLink>; Research and Development, GlaxoSmithKline plc., Research Triangle Park, NC, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101316317%22">Therapeutic advances in respiratory disease</searchLink> [Ther Adv Respir Dis] 2020 Jan-Dec; Vol. 14, pp. 1753466620965145.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Equivalence Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE+Publications%22">SAGE Publications </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101316317 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1753-4666 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217534658%22">17534658 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Respir Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33081606
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/1753466620965145
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1753466620965145
    Titles:
      – TitleFull: Effect of once-daily fluticasone furoate/vilanterol versus vilanterol alone on bone mineral density in patients with COPD: a randomized, controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Maltais F
      – PersonEntity:
          Name:
            NameFull: Schenkenberger I
      – PersonEntity:
          Name:
            NameFull: Wielders PLML
      – PersonEntity:
          Name:
            NameFull: Ortiz de Saracho J
      – PersonEntity:
          Name:
            NameFull: Chinsky K
      – PersonEntity:
          Name:
            NameFull: Watkins M
      – PersonEntity:
          Name:
            NameFull: Millar V
      – PersonEntity:
          Name:
            NameFull: Crim C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2020 Jan-Dec
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1753-4666
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Therapeutic advances in respiratory disease
              Type: main
ResultId 1